May 26, 2022 – ODQ
View a recorded version of the May 19 Office Hours webinar and a new FAQ document related to the recent updates to the alert page process
Beating cancer isn't easy. Neither is running a clinical trial. We need to do it right and do it better.
At the Dana-Farber/Harvard Cancer Center, our investigators are renowned for cutting-edge and ground-breaking science. The ODQ brings that same innovative spirit to clinical research quality and operations.
Let's move research forward. The fight against cancer is too important not to.
May 26, 2022 – ODQ
View a recorded version of the May 19 Office Hours webinar and a new FAQ document related to the recent updates to the alert page process
May 13, 2022 – CTRIO
View additional information about this upcoming Office Hours Webinar, and add to your calendar...
February 23, 2022 – Cancer Disparities
Timothy Rebbeck, PhD: Dear DF/HCC Colleagues,
I wanted to bring your attention to an event series titled, "Equity by Design in Clinical Research: Cancer Clinical Trials" with more details below. This event series begins...